Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Longevity Health HoldingsXAGE -5.83%17 Debt-to-Equity is -0.04 as of Jun. 2026. GuruFocus rates XAGE with a GF Score™ of 17/100. The stock has 4 warning signs investors should review. Among 1,765 Consumer Packaged Goods companies, Longevity Health Holdings ranks worse than 56657.17% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Longevity Health Holdings's Debt-to-Equity or its related term are showing as below:
XAGE'
s Debt-to-Equity Range Over the Past 10 Years
Min: -1.11 Med: -0.12 Max: 0.46
Current: -0.04
During the past 5 years, the highest Debt-to-Equity Ratio of Longevity Health Holdings was 0.46. The lowest was -1.11. And the median was -0.12.
XAGE's Debt-to-Equity is not ranked
in the Consumer Packaged Goods industry.
Industry Median: 0.42
vs XAGE: -0.04
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Longevity Health Holdings Debt-to-Equity Related Terms
Longevity Health Holdings Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XAGE vs SKVI, NASO, BYAH: Debt-to-Equity Comparison
For the Household & Personal Products subindustry, Longevity Health Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Longevity Health Holdings Debt-to-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Longevity Health Holdings's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Longevity Health Holdings's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Longevity Health Holdings (XAGE) has a Debt-to-Equity of -0.04 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Longevity Health Holdings and its competitors. According to the industry distribution chart, Longevity Health Holdings ranks #999999 out of 1765 companies in the Consumer Packaged Goods industry.
Is Longevity Health Holdings' Debt-to-Equity too high?
Longevity Health Holdings' current Debt-to-Equity is -0.04. Based on the distribution chart, Longevity Health Holdings ranks #999999 out of 1765 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Longevity Health Holdings has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Longevity Health Holdings' Debt-to-Equity compare to SKVI and NASO?
According to the Consumer Packaged Goods industry distribution chart, Longevity Health Holdings ranks #999999 out of 1765 companies for Debt-to-Equity. This places Longevity Health Holdings in the lower half of its industry. The industry median Debt-to-Equity is 0.42. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Consumer Packaged Goods company?
The median Debt-to-Equity among Consumer Packaged Goods companies is 0.42, based on 1,765 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Longevity Health Holdings and its competitors. For the Consumer Packaged Goods industry, the median Debt-to-Equity is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Longevity Health Holdings's current Debt-to-Equity is -0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longevity Health Holdings stock overvalued right now?
Longevity Health Holdings (XAGE) has a current Debt-to-Equity of -0.04. The current Debt-to-Equity is -0.04. Longevity Health Holdings' overall GF Score™ is 17/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Longevity Health Holdings (XAGE), the current Debt-to-Equity is -0.04 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Longevity Health Holdings Inc is a bio-aesthetics company focused on longevity and healthy aging. The company develops cosmetic skincare and haircare products designed to support skin and hair health, tailored to meet the technical requirements of professional care providers as well as retail consumers. Its product pipeline also includes regenerative bone and tissue healing solutions, although further research and development in this area has been paused. The company markets its cosmetic products in the United States through business-to-business, direct-to-consumer, and distributor sales channels.
17GF Score
Get the complete analysis for XAGE
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XAGE has been successfully added to your 
